Latest Articles
LRP1 as a potential diagnostic and immunomodulatory target in endometriosis: evidence from multi-omics and single-cell analyses - Frontiers
LRP1 as a potential diagnostic and immunomodulatory target in endometriosis: evidence from multi-omics and single-cell analyses Frontiers
Published: April 15, 2026, 10:36 a.m.
The Diagnostic Data Gap: How AI is Rewiring Clinical Infrastructure in Women’s Healthcare - The AI Journal
The Diagnostic Data Gap: How AI is Rewiring Clinical Infrastructure in Women’s Healthcare The AI Journal
Published: April 14, 2026, 9:21 a.m.
Toronto researchers use AI to tackle endometriosis diagnostic delays - CTV News
Toronto researchers use AI to tackle endometriosis diagnostic delays CTV News
Published: April 12, 2026, 9 a.m.
Contemporary Diagnostic and Therapeutic Approaches in Endometriosis: A Systematic Review - Cureus
Contemporary Diagnostic and Therapeutic Approaches in Endometriosis: A Systematic Review Cureus
Published: April 3, 2026, 8:24 a.m.
Non-invasive diagnostics in endometriosis: At the cusp of a turning point - MSN
Non-invasive diagnostics in endometriosis: At the cusp of a turning point MSN
Published: April 3, 2026, 6:53 a.m.
Non-invasive diagnostics in endometriosis: at the cusp of a turning point - Pharmaceutical Technology
Non-invasive diagnostics in endometriosis: at the cusp of a turning point Pharmaceutical Technology
Published: March 31, 2026, 4:24 p.m.
Ending the Diagnostic Delay: Feinstein Institutes’ ROSE Study Continues to Advance Critical Endometriosis Diagnostic Test - BioSpace
Ending the Diagnostic Delay: Feinstein Institutes’ ROSE Study Continues to Advance Critical Endometriosis Diagnostic Test BioSpace
Published: March 31, 2026, 4:17 p.m.
Ending the Diagnostic Delay: Feinstein Institutes’ ROSE Study Continues to Advance Critical Endometriosis Diagnostic Test - The Joplin Globe
Ending the Diagnostic Delay: Feinstein Institutes’ ROSE Study Continues to Advance Critical Endometriosis Diagnostic Test The Joplin Globe
Published: March 31, 2026, 1:02 p.m.
Ending the Diagnostic Delay: Feinstein Institutes’ ROSE Study Continues to Advance Critical Endometriosis Diagnostic Test - joplinglobe.com
Ending the Diagnostic Delay: Feinstein Institutes’ ROSE Study Continues to Advance Critical Endometriosis Diagnostic Test joplinglobe.com
Published: March 31, 2026, 1:02 p.m.
Ending the Diagnostic Delay: Feinstein Institutes’ ROSE Study Continues to Advance Critical Endometriosis Diagnostic Test - Business Wire
Ending the Diagnostic Delay: Feinstein Institutes’ ROSE Study Continues to Advance Critical Endometriosis Diagnostic Test Business Wire
Published: March 31, 2026, 1 p.m.
Link copied to clipboard!